Jonathan P Piccini
Overview
Explore the profile of Jonathan P Piccini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
581
Citations
14531
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lin A, Allen K, Gutierrez J, Piccini J, Loring Z
J Am Heart Assoc
. 2025 Mar;
14(5):e036899.
PMID: 40028844
Atrial fibrillation (AF) is the most common sustained arrhythmia and associated with increased morbidity and mortality. Differences have been identified between medical care delivered in urban and rural settings, and...
2.
Coles S, Shadrin I, Al-Khatib S, Piccini J, Sun A, Daubert J, et al.
J Cardiovasc Electrophysiol
. 2025 Jan;
PMID: 39887503
Background: The majority of data on left bundle branch area pacing (LBBAP) are on a lumenless lead. Data on the safety and effectiveness of stylet driven leads are comparatively lacking....
3.
OConnell C, Arps K, Carlisle M, Schwennesen H, Idriss S, Kanter R, et al.
JACC Clin Electrophysiol
. 2025 Jan;
11(1):120-131.
PMID: 39880539
Background: In patients with structurally normal hearts, algorithms using surface electrocardiographic P-wave morphology are helpful to predict focal atrial tachycardia (FAT) location. However, these algorithms have not been formally assessed...
4.
Butler J, Chung M, Epstein A, Guglin M, Levy W, Piccini J, et al.
J Am Coll Cardiol
. 2025 Jan;
PMID: 39808105
No abstract available.
5.
Lakkireddy D, Russo A, Hylek E, Mittal S, Peacock J, Hills M, et al.
Heart Rhythm O2
. 2025 Jan;
5(12):951-956.
PMID: 39803627
Background: Atrial fibrillation (AF) has a significant impact on health and quality of life. The relationship of AF burden and temporal patterns of AF on patient symptoms, outcomes, and healthcare...
6.
Yellepeddi V, Ismail M, Bunch T, Deering T, Holubkov R, Kennedy R, et al.
CPT Pharmacometrics Syst Pharmacol
. 2025 Jan;
PMID: 39749676
Sotalol, a class III antiarrhythmic agent, is used to maintain sinus rhythm in patients with atrial fibrillation or atrial flutter (AFIB/AFL). Despite its efficacy, sotalol's use is limited by its...
7.
Jason M, Marzec L, Piccini J, Shrader P, Pieper K, Blanco R, et al.
Int J Cardiol
. 2024 Dec;
421():132912.
PMID: 39708904
Background: Decisions about stroke prevention strategies in atrial fibrillation (AF) typically balance thromboembolism reduction against increased bleeding from oral anticoagulation therapy (OAC). When determining eligibility for OAC, guidelines recommend calculation...
8.
Tzeis S, Gerstenfeld E, Kalman J, Saad E, Sepehri Shamloo A, Andrade J, et al.
J Arrhythm
. 2024 Dec;
40(6):1217-1354.
PMID: 39669937
In the last three decades, ablation of atrial fibrillation (AF) has become an evidence-based safe and efficacious treatment for managing the most common cardiac arrhythmia. In 2007, the first joint...
9.
Kutyifa V, Christof M, Mullane S, Harrell C, Singh J, Chinitz L, et al.
Heart Rhythm O2
. 2024 Dec;
5(11):805-812.
PMID: 39651437
Background: There have been limited data examining the temporal relationship between device-derived daily activity and ventricular arrhythmias (VAs). Objective: We aimed to assess whether activity predicted VAs or VAs predicted...
10.